News | April 27, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The campaign builds on the three-year partnership unveiled earlier this season
Board approves five-year appointment, subject to shareholder nod through postal ballot
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
Company to launch product after the expiry of semaglutide patent in India
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with mCSCC or laCSCC who are not candidates for curative surgery or curative radiation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
